FDA authorization of the JUUL2 system with only tobacco- and menthol-flavored pods on August 28, 2026, anchors current trader sentiment, as the agency cited strong adult switching data while weighing youth risks. JUUL Labs' CEO immediately signaled plans for additional PMTA filings covering 5% nicotine strengths and a broader adult-focused flavor portfolio beyond the two authorized options. Earlier 2025 approvals covered similar tobacco and menthol variants for the original device, while competitors have secured limited fruit approvals, highlighting the FDA's case-by-case approach. Key catalysts ahead include JUUL's next submissions, any new flavored guidance, and potential court or policy shifts that could accelerate or block commercial U.S. availability by year-end.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedWhich flavors will JUUL relaunch in 2026?
Which flavors will JUUL relaunch in 2026?
NEW
Dec 30, 2026
Mango
44%
Mint
51%
Cucumber
52%
Fruit Medley
49%
Crème Brûlée
16%
$1,151 Vol.
Mango
$187 Vol.
44%
Mint
$160 Vol.
51%
Cucumber
$169 Vol.
52%
Fruit Medley
$89 Vol.
49%
Crème Brûlée
$546 Vol.
16%
This market will resolve to "Yes" if JUUL commercially relaunches the specified flavor in the United States between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No."
A relaunch is defined as JUUL making the specified flavor commercially available for purchase by consumers in the United States, whether through retail, direct-to-consumer, or other distribution channels. A limited release, test market, or sampling program will not constitute a relaunch.
A flavor will be considered to be the same as the specified flavor as long as the listed flavor name is entirely included in the released flavor’s name (e.g. if Juul launches “Cool Cucumber”, the option for “Cucumber” would resolve to “Yes”). Minor differences in capitalization, punctuation, or accenting will not affect this market’s resolution.
The primary resolution source for this market will be official information from Juul; however, a consensus of credible reporting may also be used.
Note: This market resolves based on commercial availability in the United States only. International relaunches will not be considered for resolution purposes.FDA authorization of the JUUL2 system with only tobacco- and menthol-flavored pods on August 28, 2026, anchors current trader sentiment, as the agency cited strong adult switching data while weighing youth risks. JUUL Labs' CEO immediately signaled plans for additional PMTA filings covering 5% nicotine strengths and a broader adult-focused flavor portfolio beyond the two authorized options. Earlier 2025 approvals covered similar tobacco and menthol variants for the original device, while competitors have secured limited fruit approvals, highlighting the FDA's case-by-case approach. Key catalysts ahead include JUUL's next submissions, any new flavored guidance, and potential court or policy shifts that could accelerate or block commercial U.S. availability by year-end.
This market will resolve to "Yes" if JUUL commercially relaunches the specified flavor in the United States between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No."
A relaunch is defined as JUUL making the specified flavor commercially available for purchase by consumers in the United States, whether through retail, direct-to-consumer, or other distribution channels. A limited release, test market, or sampling program will not constitute a relaunch.
A flavor will be considered to be the same as the specified flavor as long as the listed flavor name is entirely included in the released flavor’s name (e.g. if Juul launches “Cool Cucumber”, the option for “Cucumber” would resolve to “Yes”). Minor differences in capitalization, punctuation, or accenting will not affect this market’s resolution.
The primary resolution source for this market will be official information from Juul; however, a consensus of credible reporting may also be used.
Note: This market resolves based on commercial availability in the United States only. International relaunches will not be considered for resolution purposes.
A relaunch is defined as JUUL making the specified flavor commercially available for purchase by consumers in the United States, whether through retail, direct-to-consumer, or other distribution channels. A limited release, test market, or sampling program will not constitute a relaunch.
A flavor will be considered to be the same as the specified flavor as long as the listed flavor name is entirely included in the released flavor’s name (e.g. if Juul launches “Cool Cucumber”, the option for “Cucumber” would resolve to “Yes”). Minor differences in capitalization, punctuation, or accenting will not affect this market’s resolution.
The primary resolution source for this market will be official information from Juul; however, a consensus of credible reporting may also be used.
Note: This market resolves based on commercial availability in the United States only. International relaunches will not be considered for resolution purposes.
Market Opened: May 11, 2026, 9:33 PM ET
Volume
$1,151End Date
Dec 31, 2026Market Opened
May 11, 2026, 9:33 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if JUUL commercially relaunches the specified flavor in the United States between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No."
A relaunch is defined as JUUL making the specified flavor commercially available for purchase by consumers in the United States, whether through retail, direct-to-consumer, or other distribution channels. A limited release, test market, or sampling program will not constitute a relaunch.
A flavor will be considered to be the same as the specified flavor as long as the listed flavor name is entirely included in the released flavor’s name (e.g. if Juul launches “Cool Cucumber”, the option for “Cucumber” would resolve to “Yes”). Minor differences in capitalization, punctuation, or accenting will not affect this market’s resolution.
The primary resolution source for this market will be official information from Juul; however, a consensus of credible reporting may also be used.
Note: This market resolves based on commercial availability in the United States only. International relaunches will not be considered for resolution purposes.FDA authorization of the JUUL2 system with only tobacco- and menthol-flavored pods on August 28, 2026, anchors current trader sentiment, as the agency cited strong adult switching data while weighing youth risks. JUUL Labs' CEO immediately signaled plans for additional PMTA filings covering 5% nicotine strengths and a broader adult-focused flavor portfolio beyond the two authorized options. Earlier 2025 approvals covered similar tobacco and menthol variants for the original device, while competitors have secured limited fruit approvals, highlighting the FDA's case-by-case approach. Key catalysts ahead include JUUL's next submissions, any new flavored guidance, and potential court or policy shifts that could accelerate or block commercial U.S. availability by year-end.
This market will resolve to "Yes" if JUUL commercially relaunches the specified flavor in the United States between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No."
A relaunch is defined as JUUL making the specified flavor commercially available for purchase by consumers in the United States, whether through retail, direct-to-consumer, or other distribution channels. A limited release, test market, or sampling program will not constitute a relaunch.
A flavor will be considered to be the same as the specified flavor as long as the listed flavor name is entirely included in the released flavor’s name (e.g. if Juul launches “Cool Cucumber”, the option for “Cucumber” would resolve to “Yes”). Minor differences in capitalization, punctuation, or accenting will not affect this market’s resolution.
The primary resolution source for this market will be official information from Juul; however, a consensus of credible reporting may also be used.
Note: This market resolves based on commercial availability in the United States only. International relaunches will not be considered for resolution purposes.
A relaunch is defined as JUUL making the specified flavor commercially available for purchase by consumers in the United States, whether through retail, direct-to-consumer, or other distribution channels. A limited release, test market, or sampling program will not constitute a relaunch.
A flavor will be considered to be the same as the specified flavor as long as the listed flavor name is entirely included in the released flavor’s name (e.g. if Juul launches “Cool Cucumber”, the option for “Cucumber” would resolve to “Yes”). Minor differences in capitalization, punctuation, or accenting will not affect this market’s resolution.
The primary resolution source for this market will be official information from Juul; however, a consensus of credible reporting may also be used.
Note: This market resolves based on commercial availability in the United States only. International relaunches will not be considered for resolution purposes.
Volume
$1,151End Date
Dec 31, 2026Market Opened
May 11, 2026, 9:33 PM ETResolver
0x65070BE91...FDA authorization of the JUUL2 system with only tobacco- and menthol-flavored pods on August 28, 2026, anchors current trader sentiment, as the agency cited strong adult switching data while weighing youth risks. JUUL Labs' CEO immediately signaled plans for additional PMTA filings covering 5% nicotine strengths and a broader adult-focused flavor portfolio beyond the two authorized options. Earlier 2025 approvals covered similar tobacco and menthol variants for the original device, while competitors have secured limited fruit approvals, highlighting the FDA's case-by-case approach. Key catalysts ahead include JUUL's next submissions, any new flavored guidance, and potential court or policy shifts that could accelerate or block commercial U.S. availability by year-end.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated
Beware of external links.
Beware of external links.
Frequently Asked Questions